Drug intelligence / Profile preview

Hemoboost

Development stage: Phase 1
Lead developer: Paawan Herbal
Modality: Recombinant Proteins and Enzymes, Small Molecules
Administration: Intravenous, Intramuscular, Oral

Overview

Hemoboost is a registered natural product formulated for iron substitution. It contains specially processed haemolysed haemoglobin and iron dextran. Initially used in veterinary medicine, it is now marketed for human use, particularly for addressing symptom-producing anaemia, such as that which can occur after total knee arthroplasty. The product aims to provide iron supplementation with a focus on reducing the gastrointestinal adverse effects commonly associated with traditional iron supplements like ferrous sulphate.

Brand names: Hemoboost

Beyond the preview

Go deeper on Hemoboost.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemoboost.

Explore the full profile